Clinical Trials List
2024-10-27 - 2028-02-18
Phase I
Recruiting3
ICD-10C00.0
Malignant neoplasm of external upper lip
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9140.0
Malignant neoplasm of upper lip, vermilion border
-
Trial Applicant
Syneos Health
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/12/01
Investigators and Locations
Co-Principal Investigator
- 吳宗哲 Division of Hematology & Oncology
- 徐偉勛 醫學研究部
- YEN-SHEN LU Division of Hematology & Oncology
- 林季宏 Division of Hematology & Oncology
- 陳怡君 Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王全正 Division of Hematology & Oncology
- 林炫聿 Division of Hematology & Oncology
- 曾若涵 Division of Hematology & Oncology
- 林子棋 Division of Obstetrics & Gynecology
- 陳守棟 Division of General Surgery
- 林正純 Division of Hematology & Oncology
- 曾信順 Division of General Surgery
- 簡宏如 Division of Obstetrics & Gynecology
- 石宇閎 Division of Hematology & Oncology
- 陳子和 Division of Obstetrics & Gynecology
- 黃晟維 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
9 participants
-
Global
110 participants
